Accessibility Menu
VSee Health logo

VSee Health(NASDAQ) VSEE

Current Price$0.08
Market Cap$4.45MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-99%
5 YearN/A
1 Year-94%
1 Month-34%
VSee Health last closing stock price
MetricPriceDate
Last closeUSD 0.082026-07-22
VSee Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-24.17%USD 0.112026-07-15
1 month-33.72%USD 0.122026-06-22
3 month-62.26%USD 0.212026-04-23
Year to date-78.63%USD 0.372025-12-31
1 year-94.33%USD 1.412025-07-22
3 year-99.31%USD 11.622023-07-21
Since inception-99.19%USD 9.882021-12-31

VSee Health Financials at a Glance

Market Cap

$4.45MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$14.46M

Net Income (TTM)

-$13.35M

EPS (TTM)

-$0.54

P/E Ratio

-0.15

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.08

Volume

35,437

Open

$0.09

Previous Close

$0.08

Daily Range

$0.08 - $0.09

52-Week Range

$0.08 - $2.52

Estimated Earnings Date

Sep 28, 2026

VSEE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About VSee Health

VSee Health helps hospitals and clinics deliver remote medical care. Its software connects doctors and patients for virtual visits and monitoring. The company’s services support critical care for stroke, heart, and brain injuries.

Products and Services

  • Telehealth Software (VSee Lab): Modular platform for virtual visits, scheduling, and patient monitoring.
  • High-Acuity Telemedicine (iDoc): Remote specialist care for intensive care units.
  • Professional Services: Physician staffing, e-consultations, and clinical dashboards.
  • Patient Fees: Charges for direct patient services.
  • Technical Engineering: Custom integration and support for hospital systems.

Growth and Expansion

  • Acquired iDoc in June 2024, expanding into high-acuity telemedicine and correctional facility services.
  • Launched AI-enabled telesitter and remote patient monitoring solutions in 2025.
  • Expanded medical device sales and services, including a contract with the U.S. Department of Health and Human Services in 2025.
  • Integrated VSee Lab and iDoc platforms for unified operations post-acquisition.

What Makes VSee Health Stand Out

VSee Health’s platform lets hospitals quickly adapt workflows without coding. Its deep integration with hospital record systems supports complex care needs. The company’s AI tools help monitor patients remotely and support nursing staff.

Five Things You Need to Know

  • Revenue was $14.62 million in FY 2025, up 40% from FY 2024.
  • Gross margin was $7.36 million in FY 2025, up 2% from FY 2024.
  • Operating loss was $9.58 million in FY 2025, improved from $62.15 million in FY 2024.
  • Cash was $5.27 million at December 31, 2025; working capital deficit was $7.88 million.

Bottom Line

VSee Health has shifted from software to high-acuity telemedicine through acquisitions and new services. The company faces ongoing losses but continues to adapt its offerings for hospitals and clinics.

AI Generated • Apr 16, 2026

Industry

Health Care Technology

Sector

Health Care

Employees

209

CEO

Imoigele Aisiku, MD, MBA; Milton R. Chen, PhD

Website

www.vseehealth.com

Headquarters

Newton, MA 02458, US

VSEE Financials

Key Financial Metrics (TTM)

Gross Margin

46.30%

Operating Margin

-66.23%

Net Income Margin

-92.37%

Return on Equity

-11570.74%

Return on Capital

-121.48%

Return on Assets

-70.22%

Earnings Yield

-6.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.45MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

55.68M

Volume

35.44K

Avg. Volume

2.81M

Financials (TTM)

Gross Profit

$6.69M

Operating Income

-$9.57M

EBITDA

-$8.67M

Operating Cash Flow

-$5.46M

Capital Expenditure

-$44.80K

Free Cash Flow

-$5.50M

Cash & ST Invst.

$1.35M

Total Debt

$2.14M

VSee Health Performance Analysis

VSee Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 5,765,889N/A
20242024-12-31USD 10,421,35280.7%
20252025-12-31USD 14,618,18440.3%
VSee Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-302.1%
Q32025-09-3017.4%
Q42025-12-31-1.4%
Q12026-03-31-19.5%
VSee Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.251253.7%
20232023-12-31USD -0.3847.9%
20242024-12-31USD -5.651401.0%
20252025-12-31USD -0.73-87.1%
VSee Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3033.3%
Q32025-09-3089.1%
Q42025-12-31-1671.4%
Q12026-03-3183.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$3.16M

-4.9%

Gross Profit

$1.20M

-35.6%

Gross Margin

37.91%

N/A

Market Cap

$4.45MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$21.31K

N/A

Employees

209

N/A

Net Income

-$2.60M

+34.3%

EBITDA

-$2.04M

+19.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$1.35M

+228.2%

Total Debt

$2.14M

-22.3%

Accounts Receivable

$2.67M

+44.3%

Inventory

$0.00

N/A

Long Term Debt

$781.58K

-7.2%

Short Term Debt

$1.35M

-29.0%

Return on Assets

-70.22%

N/A

Return on Invested Capital

-1.33%

N/A

Free Cash Flow

-$2.48M

-448.0%

Operating Cash Flow

-$2.45M

-456.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CTXRCitius Pharmaceuticals, Inc.
$0.56+3.08%
BCTXBriaCell Therapeutics Corp.
$3.60-4.00%
HCTIHealthcare Triangle, Inc.
$1.76-1.12%
ADGMAdagio Medical Holdings, Inc.
$0.47+5.66%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$10.28-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.96-0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.94+0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$70.28-0.02%

Questions About VSEE

What is the current price of VSee Health?

VSee Health is trading at $0.08 per share.

What is the 52-week range for VSee Health?

Over the past 52 weeks, VSee Health has traded between $0.08 and $2.52.

How much debt does VSee Health have?

As of the most recent reporting period, VSee Health reported total debt of $2.14M.

How much cash does VSee Health have on hand?

VSee Health reported $1.35M in cash and cash equivalents in its most recent financial results.

What is VSee Health’s dividend yield?

VSee Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services